Royal Bank of Canada’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,366
| Closed | -$2K | – | 7629 |
|
|
2022
Q1 | $2K | Sell |
1,366
-3,960
| -74% | -$5.8K | ﹤0.01% | 7059 |
|
|
2021
Q4 | $12K | Buy |
5,326
+2,028
| +61% | +$4.57K | ﹤0.01% | 6483 |
|
|
2021
Q3 | $18K | Buy |
3,298
+1,196
| +57% | +$6.53K | ﹤0.01% | 6236 |
|
|
2021
Q2 | $15K | Buy |
2,102
+71
| +3% | +$507 | ﹤0.01% | 6221 |
|
|
2021
Q1 | $17K | Buy |
2,031
+863
| +74% | +$7.22K | ﹤0.01% | 6048 |
|
|
2020
Q4 | $10K | Buy |
1,168
+568
| +95% | +$4.86K | ﹤0.01% | 5846 |
|
|
2020
Q3 | $7K | Buy |
600
+573
| +2,122% | +$6.69K | ﹤0.01% | 5574 |
|
|
2020
Q2 | $0 | Sell |
27
-8
| -23% | – | ﹤0.01% | 6471 |
|
|
2020
Q1 | $0 | Sell |
35
-563
| -94% | – | ﹤0.01% | 6453 |
|
|
2019
Q4 | $3K | Buy |
598
+497
| +492% | +$2.49K | ﹤0.01% | 5908 |
|
|
2019
Q3 | $1K | Buy |
101
+1
| +1% | +$10 | ﹤0.01% | 5898 |
|
|
2019
Q2 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 5792 |
|